Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Alimentary Pharmacology & Therapeutics
|
March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
S G Lim, N Leung, H W L Hann, et al.
Transplantation Proceedings
|
November 25, 2004
Successful listing of patients for liver transplant was related to participation of referring doctor in the transplant program
C-T Wai, K Prabhakaran, M Kaur, et al.
Transplantation Proceedings
|
November 25, 2004
Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant
C-T Wai, K Prabhakaran, A Wee, et al.
Singapore Medical Journal
|
July 1, 2006
Long-term post-liver transplant complications of renal impairment and diabetes mellitus: data from Singapore
D S Sutedja, C T Wai, K F Teoh, et al.
Hepatology (Baltimore, Md.)
|
June 8, 2001
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy
N W Leung, C L Lai, T T Chang, et al.
Transplantation Proceedings
|
November 25, 2004
Persistent thrombocytopenia in liver transplant patients
D S Sutedja, C-T Wai, K-F Teoh, et al.
Singapore Medical Journal
|
July 1, 2006
Referral patterns and waiting times for liver transplantation in Singapore
S G Lim, C T Wai, M Da Costa, et al.
Singapore Medical Journal
|
July 1, 2006
Liver transplantation in Singapore 1990-2004
C T Wai, Y M Lee, D S Selamat, et al.
Transplantation Proceedings
|
November 25, 2004
Renal impairment and diabetes mellitus after liver transplant
D S Sutedja, C-T Wai, K-F Teoh, et al.
Alimentary Pharmacology & Therapeutics
|
February 26, 2013
Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B
J L Hartono, M O Aung, Y Y Dan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Alimentary Pharmacology & Therapeutics
|
March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
S G Lim, N Leung, H W L Hann, et al.
Transplantation Proceedings
|
November 25, 2004
Successful listing of patients for liver transplant was related to participation of referring doctor in the transplant program
C-T Wai, K Prabhakaran, M Kaur, et al.
Transplantation Proceedings
|
November 25, 2004
Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant
C-T Wai, K Prabhakaran, A Wee, et al.
Singapore Medical Journal
|
July 1, 2006
Long-term post-liver transplant complications of renal impairment and diabetes mellitus: data from Singapore
D S Sutedja, C T Wai, K F Teoh, et al.
Hepatology (Baltimore, Md.)
|
June 8, 2001
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy
N W Leung, C L Lai, T T Chang, et al.
Transplantation Proceedings
|
November 25, 2004
Persistent thrombocytopenia in liver transplant patients
D S Sutedja, C-T Wai, K-F Teoh, et al.
Singapore Medical Journal
|
July 1, 2006
Referral patterns and waiting times for liver transplantation in Singapore
S G Lim, C T Wai, M Da Costa, et al.
Singapore Medical Journal
|
July 1, 2006
Liver transplantation in Singapore 1990-2004
C T Wai, Y M Lee, D S Selamat, et al.
Transplantation Proceedings
|
November 25, 2004
Renal impairment and diabetes mellitus after liver transplant
D S Sutedja, C-T Wai, K-F Teoh, et al.
Alimentary Pharmacology & Therapeutics
|
February 26, 2013
Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B
J L Hartono, M O Aung, Y Y Dan, et al.
Page
of 7